This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks.com featured highlights include: Helen of Troy, eBay, Laboratory Corporation of America, ParkerHannifin and Bayer AG
by Zacks Equity Research
Zacks.com featured highlights include: Helen of Troy, eBay, Laboratory Corporation of America, ParkerHannifin and Bayer AG
5 PEG-Based Value Stocks to Buy Amid the Coronavirus Crisis
by Urmimala Biswas
While P/E alone fails to identify a true value stock, PEG helps to find the intrinsic value of a stock.
Kennametal (KMT) Briefs on Restructuring Plans & Cost Actions
by Zacks Equity Research
Kennametal's (KMT) restructuring actions will likely help it simplify the business structure, improve efficiency and boost shareholder value. Also, its cost-saving plans will likely help in effectively dealing with the pandemic-related woes.
Are Investors Undervaluing Parker-Hannifin (PH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PH vs. IEX: Which Stock Is the Better Value Option?
by Zacks Equity Research
PH vs. IEX: Which Stock Is the Better Value Option?
Here's Why You Should Consider Buying Altra Industrial Stock
by Zacks Equity Research
Altra Industrial (AIMC) is likely to gain from a diversified business structure, healthy demand for a few products, cost-reduction measures and deleveraging actions.
Donaldson's (DCI) Prospects Bleak on Coronavirus Scares
by Zacks Equity Research
Donaldson (DCI) suffers from the adverse impacts of the pandemic and keeps the projections suspended for fiscal 2020. Forex woes and high leverage are also concerning.
Why Is Parker-Hannifin (PH) Up 13.8% Since Last Earnings Report?
by Zacks Equity Research
Parker-Hannifin (PH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Parker-Hannifin (PH) Displays Bright Prospects Amid Risks
by Zacks Equity Research
Parker-Hannifin (PH) is likely to benefit from robust backlog level and acquisitions. However, high realignment expenses and the coronavirus outbreak-led market downturn remain concerning.
Parker-Hannifin (PH) Q3 Earnings and Sales Surpass Estimates
by Zacks Equity Research
Parker-Hannifin's (PH) third-quarter fiscal 2020 earnings beat estimates, while declining y/y. It withdraws earnings projections for fiscal 2020 on the pandemic-related woes.
Parker-Hannifin (PH) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Parker-Hannifin (PH) delivered earnings and revenue surprises of 29.20% and 5.66%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Industrial Stock Earnings Due on Apr 30: PH, SWK & More
by Avisekh Bhattacharjee
The impacts of the coronavirus outbreak, cost-related woes, and other headwinds are expected to get reflected in the results of the majority of industrial stocks in Q1.
Analysts Estimate Parker-Hannifin (PH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Parker-Hannifin (PH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Parker-Hannifin Benefits From Acquisitions Despite Cost Woes
by Zacks Equity Research
Parker-Hannifin (PH) to gain from its acquisitive nature, shareholder-friendly policies, unique Win Strategy and growth investments. Realignment expenses and high debts might impact near-term results.
Drab Near-Term Prospects for Industrial Manufacturing Stocks
by Avisekh Bhattacharjee
The Manufacturing - General Industrial industry is facing coronavirus-related issues, job losses & other problems. Technological advancement in manufacturing processes will likely be a growth driver.
Parker-Hannifin Discusses Strategies and Long-Term Targets
by Zacks Equity Research
Parker-Hannifin's (PH) recent investor meeting shines a light on its organic initiatives, long-term financial targets and capital allocation plans.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHMM
Is Parker-Hannifin (PH) a Profitable Stock to Pick Now?
by Zacks Equity Research
Is Parker-Hannifin (PH) a great pick from the value investor's perspective right now? Read on to know more.
Why Is Parker-Hannifin (PH) Down 9.9% Since Last Earnings Report?
by Zacks Equity Research
Parker-Hannifin (PH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHMM
Parker-Hannifin's (PH) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
Parker-Hannifin's (PH) fiscal Q2 earnings and revenues rise on a year-over-year basis.
Parker-Hannifin (PH) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Parker-Hannifin (PH) delivered earnings and revenue surprises of 10.92% and 0.99%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Parker-Hannifin (PH) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Strength in OEM and commercial aftermarket businesses is likely to have boosted Parker-Hannifin's (PH) fiscal Q2 earnings. Slowdown in global industrial end markets might have been a concern.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for JHMM
Parker-Hannifin (PH) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Parker-Hannifin (PH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.